A design thinking approach to primary ovarian insufficiency - PubMed
doi: 10.23736/S0031-0808.16.03259-6. Epub 2016 Nov 9.
Alison G Porter 1 , Vincent A Pelligrini 2 , Peter F Schnatz 2 , Xuezhi Jiang 2 , Nicole Kleinstreuer 3 , Janet E Hall 3 , Sarah Verbiest 4 , Jill Olmstead 5 , Ryan Fair 6 , Alberto Falorni 7 , Luca Persani 8 , Aleksandar Rajkovic 9 , Khanjan Mehta 10 , Lawrence M Nelson 11 ; Rachel's Well Primary Ovarian Insufficiency Community of Practice Group
Affiliations
- PMID: 27827529
- DOI: 10.23736/S0031-0808.16.03259-6
A design thinking approach to primary ovarian insufficiency
Lisa A Martin et al. Panminerva Med. 2017 Mar.
Abstract
Most clinicians are not prepared to provide integrated personal care to address all the clinical needs of women with primary ovarian insufficiency. Design thinking is an engineering methodology used to develop and evaluate novel concepts for systems operation. Here we articulate the need for a seamlessly integrated mobile health system to support genomic research as well as patient care. We also review the pathophysiology and management of primary ovarian insufficiency. Molecular understanding regarding the pathogenesis is essential to developing strategies for prevention, earlier diagnosis, and appropriate management of the disorder. The syndrome is a chronic disorder characterized by oligo/amenorrhea and hypergonadotropic hypogonadism before age 40 years. There may be significant morbidity due to: 1) depression and anxiety related to the loss of reproductive hormones and infertility; 2) associated autoimmune adrenal insufficiency or hypothyroidism; and 3) reduced bone mineral density and increased risk of cardiovascular disease related to estrogen deficiency. Approximately 5% to 10% of women with primary ovarian insufficiency conceive and have a child. Women who develop primary ovarian insufficiency related to a premutation in FMR1 are at risk of having a child with fragile X syndrome, the most common cause of inherited intellectual disability. In most cases of spontaneous primary ovarian insufficiency no environmental exposure or genetic mechanism can be identified. As a rare disease, the diagnosis of primary ovarian insufficiency presents special challenges. Connecting patients and community health providers in real time with investigators who have the requisite knowledge and expertise would help solve this dilemma.
Similar articles
-
Fragile X Associated Primary Ovarian Insufficiency (FXPOI): Case Report and Literature Review.
Fink DA, Nelson LM, Pyeritz R, Johnson J, Sherman SL, Cohen Y, Elizur SE. Fink DA, et al. Front Genet. 2018 Nov 27;9:529. doi: 10.3389/fgene.2018.00529. eCollection 2018. Front Genet. 2018. PMID: 30542367 Free PMC article. Review.
-
Falorni A, Minarelli V, Eads CM, Joachim CM, Persani L, Rossetti R, Yurttas Beim P, Pellegrini VA, Schnatz PF, Rafique S, Kissell K, Calis KA, Popat V, Nelson LM. Falorni A, et al. Panminerva Med. 2014;56(4):245-61. Epub 2014 Oct 7. Panminerva Med. 2014. PMID: 25288327 Free PMC article. Review.
-
Update on primary ovarian insufficiency in adolescents.
Gordon CM, Kanaoka T, Nelson LM. Gordon CM, et al. Curr Opin Pediatr. 2015 Aug;27(4):511-9. doi: 10.1097/MOP.0000000000000236. Curr Opin Pediatr. 2015. PMID: 26087426 Review.
-
Rebar RW. Rebar RW. Obstet Gynecol. 2009 Jun;113(6):1355-1363. doi: 10.1097/AOG.0b013e3181a66843. Obstet Gynecol. 2009. PMID: 19461434 Review.
-
Committee opinion no. 502: primary ovarian insufficiency in the adolescent.
[No authors listed] [No authors listed] Obstet Gynecol. 2011 Sep;118(3):741-745. doi: 10.1097/AOG.0b013e3182310c97. Obstet Gynecol. 2011. PMID: 21860315 Retracted.
Cited by
-
A new technology for the treatment of premature ovarian insufficiency: Cell sheet.
Calis P, Arik G, Seymen CM, Bayrak GK, Akdere OE, Yilmaz C, Saglam ASY, Gümüşderelioğlu M, Kaplanoglu GT. Calis P, et al. Cell Tissue Res. 2024 Jan;395(1):117-131. doi: 10.1007/s00441-023-03848-5. Epub 2023 Dec 5. Cell Tissue Res. 2024. PMID: 38049591
-
Optimizing Fertility in Primary Ovarian Insufficiency: Case Report and Literature Review.
Piedade KC, Spencer H, Persani L, Nelson LM. Piedade KC, et al. Front Genet. 2021 Jun 23;12:676262. doi: 10.3389/fgene.2021.676262. eCollection 2021. Front Genet. 2021. PMID: 34249096 Free PMC article.
-
Nelson LM, Spencer H, Hijane K, Thinuan P, Nelson CW, Vincent AJ, Gordon CM, Plant TM, Fazeli PK. Nelson LM, et al. Front Endocrinol (Lausanne). 2023 Sep 12;14:1227253. doi: 10.3389/fendo.2023.1227253. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37772077 Free PMC article. Review.
-
McDonald IR, Welt CK, Dwyer AA. McDonald IR, et al. Hum Reprod. 2022 Nov 24;37(12):2817-2830. doi: 10.1093/humrep/deac200. Hum Reprod. 2022. PMID: 36102839 Free PMC article.
-
Fragile X Associated Primary Ovarian Insufficiency (FXPOI): Case Report and Literature Review.
Fink DA, Nelson LM, Pyeritz R, Johnson J, Sherman SL, Cohen Y, Elizur SE. Fink DA, et al. Front Genet. 2018 Nov 27;9:529. doi: 10.3389/fgene.2018.00529. eCollection 2018. Front Genet. 2018. PMID: 30542367 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials